Biotech company BacAlt Biosciences secures Rs 18 crore in investment, spearheaded by Avaana Capital.
BacAlt Biosciences, a pioneering Indian startup founded by a team of biotechnologists, has secured Rs 18 crore in funding. The funding round was led by Avaana Capital, a venture capital fund focused on deeptech innovation, with Lubrizol InnoVentures, the co-innovation ventures platform of global speciality chemicals leader Lubrizol, also participating.
The funding will be utilised to scale BacAlt's research and development processes, strengthen hiring, and build pilot production facilities. Shruti Kutmutia, Co-Founder of BacAlt, stated that the demand for high-performance, cost-competitive ingredients is real, and they are building for scale to transition India from an import-dependent market to an export-ready bio-manufacturing hub.
BacAlt's production process sets new performance and cost standards for sustainable materials. The startup develops bio-based polymers and specialty ingredients using lean, energy-efficient, and high-throughput fermentation. The process is low-carbon due to waste valorisation, circular feedstocks, and non-sterile fermentation.
Shruti Srivastava, Investment Director at Avaana Capital, mentioned that by combining proprietary fermentation platforms with the circular use of agricultural waste, BacAlt is delivering ingredients that meet the performance and cost thresholds required for scale in FMCG, positioning the company at the forefront of sustainable materials for mainstream markets.
BacAlt's products improve product performance in diverse applications while preventing microplastic pollution. The products are offered at mass-market viable cost points without reliance on synthetics. The startup plans to develop go-to-market strategies for geographic expansion.
BacAlt's vision is to establish India as a global hub for circular, bio-based specialty ingredients. The startup's success could potentially reduce India's dependence on imported ingredients and contribute to the country's export growth in the bio-manufacturing sector.
As for the exact location of BacAlt Biosciences, no search results could be found. However, with the funding secured and plans for expansion, it is expected that more details about the startup's location will be revealed in due course.
With this funding round, BacAlt Biosciences is poised to make a significant impact in the bio-manufacturing sector, providing formulators in sectors like home care, personal care, agrochemicals, nutraceuticals, and pharmaceuticals with advanced textures, functionalities, and stability. The startup's commitment to sustainability and cost-effectiveness could pave the way for a more eco-friendly and economically viable future in the production of specialty ingredients.
Read also:
- EA Relies on Madden and Battlefield to Drive Microtransactions Recovery
- Expense for Creating a Digital Platform for Fantasy Sports
- AI-Enhanced Battery-Swapping Station in Southeast Asia Officially Opens Its Doors
- Honda unveils blueprint for design, advanced driver assistance systems, electric vehicles, fuel efficiency, and technology development
